- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Elosulfase alfa – March 2016
Elosulfase alfa: 5mg/5mL injection, 5 mL vial, Vimizim®
Last updated
1 July 2016